Of note, recently, either partially or just poorly selective MMP-9 inhibitors have been shown to offer therapeutic potential towards epileptogenesis [23,24,25,26], further supporting the need to assess a role of MMP-9 in post-stroke epileptogenesis. The gene discussed is MMP9; the disease is Stroke.